Nov 08, 2022 4:30pm EST Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
Nov 03, 2022 9:00am EDT Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
Aug 19, 2022 4:01pm EDT Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 08, 2022 4:30pm EDT Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
Jul 26, 2022 4:01pm EDT Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck
Jul 12, 2022 7:00am EDT Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs
